Filtered By:
Vaccination: Varicella-Zoster Virus Vaccine
This page shows you your search results in order of relevance. This is page number 13.
Order by Relevance | Date
Total 2327 results found since Jan 2013.
Zoster meningitis in an immunocompetent young patient post first dose of BNT162b2 mRNA COVID-19 vaccine, a case report
We describe the case of VZV meningitis post BNT162b2 mRNA vaccination in a young immunocompetent patient. A 39-year-old patient with no medical history presented with a vesicular rash, headache, nausea and fever, days after receiving BNT162b2 mRNA vaccination. CSF analysis revealed a pleocytosis, and VZV DNA was confirmed by PCR testing. The patient received intravenous aciclovir with resolution of symptoms within 48 h. He was discharged after 14 days of treatment. Case reports of herpes zoster reactivation post vaccination and details of subsequent successful vaccination course completion have allowed us to recommend the ...
Source: Herpes - February 21, 2022 Category: Infectious Diseases Authors: Colm Kerr Susan O'Neill Anna Szucs Oliver Darmody Claire Williamson Ciaran Bannan Concepta Merry Source Type: research
COVID-19 mRNA vaccine in pregnancy: Results of the Swiss COVI-PREG registry, an observational prospective cohort study
Lancet Reg Health Eur. 2022 May 29;18:100410. doi: 10.1016/j.lanepe.2022.100410. eCollection 2022 Jul.ABSTRACTBACKGROUND: Pregnant individuals with coronavirus disease 2019 (COVID-19) are at increased risk of severe disease, prematurity, and stillbirth. In March 2021, vaccination for at risk pregnant women was recommended in Switzerland, expanding this to all pregnant women in May 2021. Our aim was to assess the safety of mRNA COVID-19 vaccines in pregnancy.METHODS: This multicentre prospective cohort study describes early adverse events and perinatal outcomes in pregnant women who received at least one dose of mRNA vaccin...
Source: Herpes - June 2, 2022 Category: Infectious Diseases Authors: Guillaume Favre Emeline Maisonneuve L éo Pomar Ursula Winterfeld Charlotte Daire Bego ña Martinez de Tejada Dominique Delecraz Sonia Campelo Mirjam Moser Monya Todesco-Bernasconi Stefanie Sturm Irene H ösli C écile Monod Brigitte Frey Tirri Stylianos Source Type: research
Clinical and epidemiological aspects of herpes zoster disease in a primary care setting in Riyadh, Saudi Arabia: A retrospective cohort study
CONCLUSIONS: Zoster vaccination uptake was low. A national program for adult vaccination, including zoster vaccination, should be developed, and a guideline to direct primary health-care professionals in the management of HZ infections should be implemented.PMID:36618136 | PMC:PMC9810876 | DOI:10.4103/jfmpc.jfmpc_933_22
Source: Herpes - January 9, 2023 Category: Infectious Diseases Authors: Abdullah S Binsaeedu Abubakr O Bajaber Aiman G Muqrad Yaser A Alendijani Hamad A Alkhenizan Thamer A Alsulaiman Abdullah H Alkhenizan Source Type: research
Clinical characteristics of SARS-CoV-2 vaccine-related acute appendicitis
CONCLUSION: With the exception of older age, the clinical characteristics of patients presenting with acute appendicitis within 21 days of receiving the SARS-CoV-2 vaccination did not differ from those of patients who presented with acute appendicitis not related to the vaccination. This finding suggests that vaccine-related acute appendicitis is similar to "classic" acute appendicitis.PMID:37225246 | PMC:PMC10228661 | DOI:10.1503/cjs.009322
Source: Canadian Journal of Surgery - May 24, 2023 Category: Surgery Authors: Elchanan Quint Ivan Kukeev Itai Hazan Daniel Grupel Oleg Dukhno Anton Osyntsov Gilbert Sebbag Ohad Guetta David Czeiger Source Type: research
Safety and immunogenicity of a skin- and neuro-attenuated live vaccine for varicella: a randomized, double-blind, controlled, dose-escalation and age de-escalation phase 1 clinical trial
Lancet Reg Health West Pac. 2023 Feb 18;34:100707. doi: 10.1016/j.lanwpc.2023.100707. eCollection 2023 May.ABSTRACTBACKGROUND: Despite the success in decreasing varicella-related disease burden, live-attenuated Oka vaccine strain of varicella-zoster virus (vOka) remains neuro-virulence and may establish latency and reactivate, raising safety concerns. Here we aimed to evaluate the safety and immunogenicity of a skin- and neuro-attenuated varicella vaccine candidate (v7D).METHODS: This is a randomized, double-blind, placebo-controlled, dose-escalation and age de-escalation phase 1 clinical trial conducted in Liuzhou, China ...
Source: Herpes - June 7, 2023 Category: Infectious Diseases Authors: Zhao-Jun Mo Shou-Jie Huang Ling-Xian Qiu Chang-Gui Li Xiao-Juan Yu Ming-Qiang Li Zhen Chen Guo-Hua Zhong De-Quan Pan Li-Rong Huang Bang-Jun Lv Xue-Lian Cui Qiao-Qiao Song Ji-Zong Jia Jin-Le Han Wei Wang Hua Zhu Tong Cheng Ying-Ying Su Yi-Min Li Xiang-Zhon Source Type: research
Clinical characteristics of SARS-CoV-2 vaccine-related acute appendicitis
CONCLUSION: With the exception of older age, the clinical characteristics of patients presenting with acute appendicitis within 21 days of receiving the SARS-CoV-2 vaccination did not differ from those of patients who presented with acute appendicitis not related to the vaccination. This finding suggests that vaccine-related acute appendicitis is similar to "classic" acute appendicitis.PMID:37225246 | PMC:PMC10228661 | DOI:10.1503/cjs.009322
Source: Canadian Journal of Surgery - May 24, 2023 Category: Surgery Authors: Elchanan Quint Ivan Kukeev Itai Hazan Daniel Grupel Oleg Dukhno Anton Osyntsov Gilbert Sebbag Ohad Guetta David Czeiger Source Type: research
Causal evidence that herpes zoster vaccination prevents a proportion of dementia cases
medRxiv. 2023 May 25:2023.05.23.23290253. doi: 10.1101/2023.05.23.23290253. Preprint.ABSTRACTThe root causes of dementia are still largely unclear, and the medical community lacks highly effective preventive and therapeutic pharmaceutical agents for dementia despite large investments into their development. There is growing interest in the question if infectious agents play a role in the development of dementia, with herpesviruses attracting particular attention. To provide causal as opposed to merely correlational evidence on this question, we take advantage of the fact that in Wales eligibility for the herpes zoster vacc...
Source: Herpes - June 9, 2023 Category: Infectious Diseases Authors: Markus Eyting Min Xie Simon He ß Simon He ß Pascal Geldsetzer Source Type: research
Clinical characteristics of SARS-CoV-2 vaccine-related acute appendicitis
CONCLUSION: With the exception of older age, the clinical characteristics of patients presenting with acute appendicitis within 21 days of receiving the SARS-CoV-2 vaccination did not differ from those of patients who presented with acute appendicitis not related to the vaccination. This finding suggests that vaccine-related acute appendicitis is similar to "classic" acute appendicitis.PMID:37225246 | PMC:PMC10228661 | DOI:10.1503/cjs.009322
Source: Canadian Journal of Surgery - May 24, 2023 Category: Surgery Authors: Elchanan Quint Ivan Kukeev Itai Hazan Daniel Grupel Oleg Dukhno Anton Osyntsov Gilbert Sebbag Ohad Guetta David Czeiger Source Type: research
Causal evidence that herpes zoster vaccination prevents a proportion of dementia cases
medRxiv. 2023 May 25:2023.05.23.23290253. doi: 10.1101/2023.05.23.23290253. Preprint.ABSTRACTThe root causes of dementia are still largely unclear, and the medical community lacks highly effective preventive and therapeutic pharmaceutical agents for dementia despite large investments into their development. There is growing interest in the question if infectious agents play a role in the development of dementia, with herpesviruses attracting particular attention. To provide causal as opposed to merely correlational evidence on this question, we take advantage of the fact that in Wales eligibility for the herpes zoster vacc...
Source: Herpes - June 9, 2023 Category: Infectious Diseases Authors: Markus Eyting Min Xie Simon He ß Simon He ß Pascal Geldsetzer Source Type: research
